Abstract
Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood.v128.22.3738.3738
Journal: Blood | Publication Date: Dec 2, 2016 |
Citations: 2 |
Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
Join us for a 30 min session where you can share your feedback and ask us any queries you have